Barclays PLC Agilent Technologies, Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Barclays PLC holds 968,007 shares of A stock, worth $126 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

968,007

Previous 800,380 20.94%

Holding current value

$126 Million

Previous $111 Million 26.58%

% of portfolio

0.05%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$128.12 - $149.31 $21.5 Million - $25 Million	167,627 Added 20.94%	968,007 $141 Million
Q4 2023 Feb 15, 2024	BUY	$101.17 - $139.82 $16.6 Million - $23 Million	164,281 Added 25.83%	800,380 $111 Million
Q3 2023 Nov 07, 2023	BUY	$109.73 - $128.47 $10.7 Million - $12.5 Million	97,241 Added 18.05%	636,099 $71.1 Million
Q2 2023 Aug 03, 2023	BUY	$114.69 - $141.28 $29.8 Million - $36.8 Million	260,186 Added 93.37%	538,858 $64.8 Million
Q1 2023 May 04, 2023	SELL	$131.13 - $159.06 $22.7 Million - $27.6 Million	-173,489 Reduced 38.37%	278,672 $38.6 Million

Q4 2022 Feb 13, 2023	BUY	$125.64 - $157.68 $15.6 Million - $19.6 Million	124,494 Added 37.99%	452,161 $67.7 Million
Q3 2022 Nov 03, 2022	BUY	$115.11 - $142.29 $5.73 Million - $7.08 Million	49,738 Added 17.9%	327,667 $39.8 Million
Q2 2022 Aug 12, 2022	SELL	$112.71 - $135.93 $32.6 Million - $39.3 Million	-288,872 Reduced 50.97%	277,929 $33 Million
Q1 2022 May 16, 2022	SELL	$126.0 - $156.48 $1.73 Million - $2.15 Million	-13,751 Reduced 2.37%	566,801 $75 Million
Q4 2021 Feb 14, 2022	SELL	$147.95 - $164.3 $5 Million - $5.55 Million	-33,762 Reduced 5.5%	580,552 $92.7 Million
Q3 2021 Nov 09, 2021	BUY	$147.58 - $179.28 $14.3 Million - $17.4 Million	96,921 Added 18.73%	614,314 $96.8 Million
Q2 2021 Aug 13, 2021	BUY	$127.69 - $148.81 $12.9 Million - $15 Million	101,089 Added 24.28%	517,393 $76.5 Million
Q1 2021 May 13, 2021	SELL	$114.99 - $130.12 $18.4 Million - $20.8 Million	-159,686 Reduced 27.72%	416,304 $52.9 Million
Q4 2020 Feb 11, 2021	BUY	$100.01 - $119.3 $20.8 Million - $24.8 Million	208,210 Added 56.61%	575,990 $68.2 Million
Q3 2020 Nov 12, 2020	BUY	$88.11 - $103.42 $8.73 Million - $10.2 Million	99,035 Added 36.85%	367,780 $37.1 Million
Q2 2020 Aug 12, 2020	BUY	$68.92 - $91.14 $3.11 Million - $4.12 Million	45,165 Added 20.2%	268,745 $23.7 Million
Q1 2020 May 13, 2020	SELL	$63.37 - $90.13 $17.2 Million - $24.5 Million	-271,975 Reduced 54.88%	223,580 $16 Million
Q4 2019 Feb 10, 2020	BUY	$72.49 - $85.45 $4.7 Million - $5.54 Million	64,860 Added 15.06%	495,555 $42.3 Million
Q3 2019 Nov 14, 2019	SELL	$65.59 - $78.07 $7.28 Million - $8.67 Million	-111,045 Reduced 20.5%	430,695 $33 Million
Q2 2019 Aug 14, 2019	BUY	$66.89 - $81.94 $10.7 Million - $13.1 Million	160,423 Added 42.07%	541,740 $40.5 Million
Q1 2019 May 15, 2019	SELL	$63.27 - $82.0 $12.1 Million - $15.7 Million	-191,263 Reduced 33.4%	381,317 $30.7 Million
Q4 2018 Feb 14, 2019	BUY	$61.13 - $74.67 $6.54 Million - $7.99 Million	107,032 Added 22.99%	572,580 $38.6 Million
Q3 2018 Nov 14, 2018	BUY	$61.25 - $71.13 $3.65 Million - $4.23 Million	59,513 Added 14.66%	465,548 $32.8 Million
Q2 2018 Aug 14, 2018	SELL	$61.14 - $69.55 $22.4 Million - $25.5 Million	-366,758 Reduced 47.46%	406,035 $25.1 Million
Q1 2018 May 15, 2018	SELL	$65.05 - $74.82 $3.5 Million - $4.03 Million	-53,818 Reduced 6.51%	772,793 $51.7 Million
Q4 2017 Feb 14, 2018	BUY	$64.87 - $70.59 $29.4 Million - $32 Million	453,683 Added 121.65%	826,611 $55.4 Million
Q3 2017 Nov 14, 2017	BUY	$58.57 - $66.17 $21.8 Million - $24.7 Million	372,928	372,928 $23.9 Million

Others Institutions Holding A

# of Institutions

1,089

Shares Held

262M

Call Options Held

912K

Put Options Held

777K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $38.6B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account